The first patient was dosed in the Phase 1 ZOLAR 7 trial of TLX300-CDx ( 89 Zr-olaratumab), which aims to validate the use of olaratumab, an antibody exclusively licensed from Eli Lilly and Company ...

Learn how to craft a memorable business name with these expert tips, designed to drive growth, build trust, and ensure ...